Kratzer W, Mason R A, Janowitz P, Tudyka J, Maier C, Wechsler J G, Adler G
Abteilung für Endokrinologie, Ernährungswissenschaft, Gastroenterologie und Stoffwechselkrankheiten, Universität Ulm.
Z Gastroenterol. 1994 Mar;32(3):170-3.
To determine the risk of gallbladder stone recurrence in these patients, 58 of the first consecutive 61 patients with solitary stones achieving complete stone clearance after ESWL and adjuvant bile acid therapy were included in a prospective study. All patients were observed for at least 12 months following discontinuation of oral bile acids. Twenty-one patients fulfilled our postulated ideal criteria (solitary radiolucent stones between 10-20 mm initial diameter, initial stone density < 50 HU, gallbladder ejection fraction > 70%). The remaining patients (n = 37) fulfilled the criteria of the Munich study group. In patients fulfilling our ideal criteria, stone recurrence was not observed in any patient, while in those fulfilling solely the criteria of the Munich group, five instances of stone recurrence were observed (13.5% [n = 37], p < 0.1). Initial stone count is only one factor influencing the probability of gallstone recurrence following ESWL and discontinuation of oral bile acids. Our data suggest that factors such as low initial stone density at gallbladder CT and good gallbladder function not only accelerate initial stone clearance but also reduce the risk of stone recurrence after ESWL once oral bile acids have been discontinued.
为了确定这些患者胆囊结石复发的风险,在一项前瞻性研究中纳入了连续61例经体外冲击波碎石术(ESWL)和辅助胆汁酸治疗后结石完全清除的孤立性结石患者中的58例。所有患者在停用口服胆汁酸后至少观察12个月。21例患者符合我们假定的理想标准(初始直径为10 - 20 mm的孤立性透光结石,初始结石密度<50 HU,胆囊射血分数>70%)。其余患者(n = 37)符合慕尼黑研究组的标准。在符合我们理想标准的患者中,未观察到任何患者结石复发,而在仅符合慕尼黑组标准的患者中,观察到5例结石复发(13.5% [n = 37],p < 0.1)。初始结石数量只是影响ESWL后及停用口服胆汁酸后胆结石复发概率的一个因素。我们的数据表明,胆囊CT检查时初始结石密度低和胆囊功能良好等因素不仅能加速初始结石清除,而且在停用口服胆汁酸后还能降低ESWL后结石复发的风险。